| Released | Contributor | Author | Title | Pages | Price | | 29-Nov-2009 | PriceTarget Research, Inc. |
N/A
| IDEXX Laboratories has a current Overall Rating of B (Positive). | 7 |
$25 | | 25-Nov-2009 | New Constructs, LLC |
N/A
| IDXX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 | | 24-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for MEDICAL SUPPLIES | 18 |
$49 | | 24-Nov-2009 | Stock Traders Daily | Thomas H. Kee Jr. | Trading Report for (IDXX). A detailed Technical Analysis + Trading Plans for Day Trading, Swing Trading, and Long Term proactive investments in (IDXX). | 5 |
$18 | | 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 | 569 |
$299 | | 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Market Research and Competitive Analysis 2010 | 730 |
$299 | | 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Health Care Industry Trends, Statistics & Analysis 2010 (Summary) | 98 |
$199 | | 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Plunkett's Health Care Technologies Overview 2010 (Summary) | 80 |
$199 | | 23-Nov-2009 | Plunkett Research, Ltd. | Jack W. Plunkett | Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) | 71 |
$199 | | 23-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for IDXX | 13 |
$25 |
|
0.22% Nasdaq 
Research Reports
